University of Texas Health Science Center at Houston: Drug Significantly Reduces Chorea Symptoms in Patients With Huntington's Disease
May 20, 2023
May 20, 2023
HOUSTON, Texas, May 20 (TNSjou) -- The University of Texas Health Science Center at Houston issued the following news on May 19, 2023:
The drug valbenazine statistically improves chorea, a movement disorder commonly associated with Huntington's disease, when compared to a placebo, according to a recent international study led by UTHealth Houston researcher Erin Furr Stimming, MD, who served as principal investigator on behalf of the KINECT-HD Huntington Study Group.
The . . .
The drug valbenazine statistically improves chorea, a movement disorder commonly associated with Huntington's disease, when compared to a placebo, according to a recent international study led by UTHealth Houston researcher Erin Furr Stimming, MD, who served as principal investigator on behalf of the KINECT-HD Huntington Study Group.
The . . .